Home/Tiba Biotech/Karl Ruping

KR

Karl Ruping

Chief Executive Officer

Therapeutic Areas

Infectious Diseases Oncology Genetic Diseases Autoimmune Diseases

Tiba Biotech Pipeline

Drug	Indication	Phase
Influenza Vaccine(s)	Seasonal/Pandemic Influenza	Pre-clinical
Immuno-oncology Program	Oncology	Discovery
Gene Therapy/Gene Editing Program	Genetic Diseases	Discovery

Leadership Team at Tiba Biotech

Christian Mandl, PhD, MD

Chief Medical Officer

Jasdave Chahal, PhD

Chief Scientific Officer

Chief Financial Officer

Poulami Talukder, PhD

Principal Scientist - Delivery

R. Michael Raab, PhD

BOD/Engineering

View full Tiba Biotech profile